Smartest Doc
Rate of Postprocedural Stroke and Death in SAMMPRIS Trial–Eligible Patients Treated With Intracranial Angioplasty and/or Stent Placement in Practice
Neurosurgery, 07/11/2012
Siddiq F et al. – The overall 30–day postprocedure stroke and death rate in this study was lower in both SAMMPRIS (Stenting vs Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis)–eligible and –ineligible groups than the reported 14% stroke and death rate in the SAMMPRIS trial. The authors hypothesize that a more judicious use of primary angioplasty may be responsible for better postprocedure outcomes and should be considered an acceptable treatment in future trials.
